CELLEBRITE DI LTD (CLBT) Fundamental Analysis & Valuation
NASDAQ:CLBT • IL0011794802
Current stock price
14.16 USD
-0.05 (-0.35%)
At close:
14.09 USD
-0.07 (-0.49%)
Pre-Market:
This CLBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CLBT Profitability Analysis
1.1 Basic Checks
- In the past year CLBT was profitable.
- In the past year CLBT had a positive cash flow from operations.
- In multiple years CLBT reported negative net income over the last 5 years.
- CLBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- CLBT has a better Return On Assets (8.29%) than 83.09% of its industry peers.
- CLBT has a better Return On Equity (16.07%) than 84.17% of its industry peers.
- CLBT's Return On Invested Capital of 10.09% is amongst the best of the industry. CLBT outperforms 84.89% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CLBT is in line with the industry average of 10.92%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.29% | ||
| ROE | 16.07% | ||
| ROIC | 10.09% |
ROA(3y)-15.97%
ROA(5y)0.32%
ROE(3y)-101.74%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
1.3 Margins
- The Profit Margin of CLBT (16.36%) is better than 82.73% of its industry peers.
- In the last couple of years the Profit Margin of CLBT has declined.
- Looking at the Operating Margin, with a value of 13.98%, CLBT belongs to the top of the industry, outperforming 80.94% of the companies in the same industry.
- CLBT's Operating Margin has improved in the last couple of years.
- CLBT has a Gross Margin of 84.20%. This is amongst the best in the industry. CLBT outperforms 90.29% of its industry peers.
- CLBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.98% | ||
| PM (TTM) | 16.36% | ||
| GM | 84.2% |
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.48%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
2. CLBT Health Analysis
2.1 Basic Checks
- CLBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- CLBT has more shares outstanding than it did 1 year ago.
- CLBT has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- CLBT has an Altman-Z score of 5.54. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
- CLBT's Altman-Z score of 5.54 is fine compared to the rest of the industry. CLBT outperforms 79.50% of its industry peers.
- There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.54 |
ROIC/WACC1.18
WACC8.53%
2.3 Liquidity
- A Current Ratio of 1.56 indicates that CLBT should not have too much problems paying its short term obligations.
- CLBT's Current ratio of 1.56 is in line compared to the rest of the industry. CLBT outperforms 47.12% of its industry peers.
- A Quick Ratio of 1.54 indicates that CLBT should not have too much problems paying its short term obligations.
- CLBT has a Quick ratio of 1.54. This is comparable to the rest of the industry: CLBT outperforms 46.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.54 |
3. CLBT Growth Analysis
3.1 Past
- CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.05%, which is quite good.
- Measured over the past years, CLBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 71.00% on average per year.
- The Revenue has grown by 18.56% in the past year. This is quite good.
- CLBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%
3.2 Future
- The Earnings Per Share is expected to grow by 16.40% on average over the next years. This is quite good.
- CLBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.23% yearly.
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. CLBT Valuation Analysis
4.1 Price/Earnings Ratio
- CLBT is valuated quite expensively with a Price/Earnings ratio of 28.32.
- CLBT's Price/Earnings ratio is in line with the industry average.
- When comparing the Price/Earnings ratio of CLBT to the average of the S&P500 Index (25.61), we can say CLBT is valued inline with the index average.
- A Price/Forward Earnings ratio of 25.44 indicates a quite expensive valuation of CLBT.
- CLBT's Price/Forward Earnings ratio is in line with the industry average.
- CLBT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.32 | ||
| Fwd PE | 25.44 |
4.2 Price Multiples
- CLBT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 62.59% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 68.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.03 | ||
| EV/EBITDA | 35.51 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CLBT has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as CLBT's earnings are expected to grow with 16.24% in the coming years.
PEG (NY)2.5
PEG (5Y)N/A
EPS Next 2Y12.57%
EPS Next 3Y16.24%
5. CLBT Dividend Analysis
5.1 Amount
- CLBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CLBT Fundamentals: All Metrics, Ratios and Statistics
14.16
-0.05 (-0.35%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11 2026-02-11/bmo
Earnings (Next)05-12 2026-05-12
Inst Owners49.03%
Inst Owner Change-3.9%
Ins Owners0.63%
Ins Owner Change0%
Market Cap3.53B
Revenue(TTM)475.68M
Net Income(TTM)77.81M
Analysts83.08
Price Target22.44 (58.47%)
Short Float %3.92%
Short Ratio2.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.42%
Min EPS beat(2)1.3%
Max EPS beat(2)9.55%
EPS beat(4)4
Avg EPS beat(4)9.89%
Min EPS beat(4)1.3%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)28.1%
EPS beat(12)12
Avg EPS beat(12)50.82%
EPS beat(16)13
Avg EPS beat(16)30.81%
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.34%
PT rev (1m)-10.81%
PT rev (3m)-10.98%
EPS NQ rev (1m)-8.5%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)1.11%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)-2.9%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)2.08%
Revenue NY rev (3m)2.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.32 | ||
| Fwd PE | 25.44 | ||
| P/S | 7.43 | ||
| P/FCF | 22.03 | ||
| P/OCF | 20.35 | ||
| P/B | 7.29 | ||
| P/tB | 12.47 | ||
| EV/EBITDA | 35.51 |
EPS(TTM)0.5
EY3.53%
EPS(NY)0.56
Fwd EY3.93%
FCF(TTM)0.64
FCFY4.54%
OCF(TTM)0.7
OCFY4.91%
SpS1.91
BVpS1.94
TBVpS1.14
PEG (NY)2.5
PEG (5Y)N/A
Graham Number4.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.29% | ||
| ROE | 16.07% | ||
| ROCE | 11.68% | ||
| ROIC | 10.09% | ||
| ROICexc | 43.46% | ||
| ROICexgc | N/A | ||
| OM | 13.98% | ||
| PM (TTM) | 16.36% | ||
| GM | 84.2% | ||
| FCFM | 33.7% |
ROA(3y)-15.97%
ROA(5y)0.32%
ROE(3y)-101.74%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.66%
ROCE(5y)11.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y205.37%
ROICexc growth 5YN/A
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.48%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
F-Score5
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.44% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 221.51% | ||
| Profit Quality | 206.03% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.54 | ||
| Altman-Z | 5.54 |
F-Score5
WACC8.53%
ROIC/WACC1.18
Cap/Depr(3y)96.85%
Cap/Depr(5y)101.03%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y11.32%
EPS Next 2Y12.57%
EPS Next 3Y16.24%
EPS Next 5Y16.4%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5Y16.23%
EBIT growth 1Y16.82%
EBIT growth 3Y305.1%
EBIT growth 5Y48.52%
EBIT Next Year28.35%
EBIT Next 3Y23.3%
EBIT Next 5Y22.88%
FCF growth 1Y31.88%
FCF growth 3Y140.74%
FCF growth 5Y21.59%
OCF growth 1Y31.3%
OCF growth 3Y103.54%
OCF growth 5Y21.14%
CELLEBRITE DI LTD / CLBT Fundamental Analysis FAQ
What is the fundamental rating for CLBT stock?
ChartMill assigns a fundamental rating of 6 / 10 to CLBT.
What is the valuation status of CELLEBRITE DI LTD (CLBT) stock?
ChartMill assigns a valuation rating of 4 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Fairly Valued.
What is the profitability of CLBT stock?
CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.
How financially healthy is CELLEBRITE DI LTD?
The financial health rating of CELLEBRITE DI LTD (CLBT) is 7 / 10.
What is the expected EPS growth for CELLEBRITE DI LTD (CLBT) stock?
The Earnings per Share (EPS) of CELLEBRITE DI LTD (CLBT) is expected to grow by 11.32% in the next year.